Navigation Links
Cervical Cancer Vaccine Well Tolerated
Date:12/4/2008

Reactions such as hives called 'idiosyncratic,' study finds

THURSDAY, Dec. 4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after more than 380,000 doses of the Gardasil vaccine were given to girls in secondary schools beginning in April 2007.

Gardasil protects against four types of human papillomavirus (HPV) that increase the risk of cervical cancer. Some ingredients of the vaccine, such as aluminum salts and yeasts, have previously been associated with hypersensitivity reactions.

The Australian researchers identified 35 schoolgirls with suspected hypersensitivity reactions, including hives, generalized rash, swelling of subcutaneous tissues (angioedema), and severe allergic reaction (anaphylaxis).

Twenty-five of the girls agreed to be referred to pediatric allergy centers for further evaluation. This included a detailed account of their reactions, such as previous doses of the vaccine, time and severity of reaction, and previous clinical history. Skin tests of HPV vaccines were conducted, and vaccine challenges were administered intramuscularly. The girls were followed-up by telephone one week after the subsequent dose, and any adverse events were noted, the researchers said.

Nineteen girls had skin testing of the Gardasil vaccine, and all were negative. Seventeen of 18 girls later "challenged" with the vaccine tolerated further doses. One girl reported a limited case of hives four hours after receiving the vaccine. Only three of the 25 evaluated girls had probable hypersensitivity to the vaccine, and the researchers concluded that true hypersensitivity is rare.

They noted that suspected hypersensitivity reactions such as hives are often "idiosyncratic" and don't increase the risk of adverse reactions in subsequent vaccinations. Girls with suspected hypersensitivity to the vaccine should be evaluated before receiving further doses, said the researchers, who called for more research into the mechanisms of hypersensitivity to the vaccine.

The study was published online Dec. 3 in the BMJ.

More information

The U.S. National Cancer Institute has more about HPV vaccines.



-- Robert Preidt



SOURCE: British Medical Journal, news release, Dec. 3, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Cervical cancer screening: Too many are left unprotected
2. Couples more likely to divorce if spouse develops cervical or testicular cancer
3. Gene-Based Screen Spots Cervical Cancer Earlier
4. Transcutaneous cervical esophageal ultrasound can not substitute for 24-h pH monitoring or manometry
5. Advaxis, Inc. phase I/II results of lovaxin C in cervical cancer study released
6. Study: HPV test beats Pap in detecting cervical cancer
7. NEJM Report Finds HPV Test More Effective Than Pap in Determining Cervical Cancer Risk
8. Pa. Funding for Cervical Cancer Prevention Services Ends
9. Precancerous Lesions Raise Cervical Cancer Risk
10. American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening
11. Study Finds New Version of QIAGENs HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... Hills Estates, CA (PRWEB) , ... January 24, 2017 , ... ... performance at studies, work, athletics or even in relationships. Course offered by Dr. ... fee is necessary due to limited seating and the many hands-on experiences. ...
(Date:1/24/2017)... ... January 24, 2017 , ... West’s Health ... annual Solutions Series of webinars will start January 31 with a session about ... of current health and benefits topics, including employee engagement, pricing transparency, population health ...
(Date:1/24/2017)... TX (PRWEB) , ... January 24, 2017 , ... Bellus ... the company’s team of medical experts. In his new role Dr. Dobke will provide ... , Dr. Dobke is the Head of Plastic Surgery and Associate Professor of ...
(Date:1/24/2017)... Chapel Hill, N.C. (PRWEB) , ... January 24, ... ... the Trump Administration is the focus of a new report from the ... Carolina Kenan-Flagler Business School. , Influential business leaders, academics and policy makers identified ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... The results ... news for everyone and particularly good news for prostate cancer patients: incidents of cancer ... , According to the report the cancer death rate has dropped from its peak ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... -- In a major study released this weekend from ... 1 ( http://www.multivu.com/players/English/7899551-nephrocheck-test-acute-kidney-injury-outcomes/ ), Astute Medical,s ... patients at high risk of Acute Kidney Injury ... control trial led by Alexander Zarbock , ... standard of care or a treatment per Kidney ...
(Date:1/24/2017)... , Jan. 24, 2017 Market Research Future has a half ... Wound Closure Device is growing rapidly and expected to continue its growth ... ... CAGR of 5% from 2013 to 2019 and reaching a value of ... forecasted period, 2016-2022 Global Wound Closure Device Market has been ...
(Date:1/24/2017)... Jan. 24, 2017  The Orthopaedic Implant Company ... high-value orthopaedic implants, announced the launch of its ... The OIC Tibial Nail System is designed ... proximal and distal screw holes accommodate varying fracture ... dynamization.  The nail is available in diameters of ...
Breaking Medicine Technology: